Long-term Sedation With Remimazolam Besylate in Critically Ill Patients
Status:
Not yet recruiting
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
A randomized non-inferior trial comparing remimazolam besylate with propofol for long-term
sedation during invasive mechanical ventilation in critically ill patients